ISR - AngioDynamics launches Auryon Atherectomy System in U.S.

AngioDynamics (ANGO) has launched Auryon Atherectomy System, a newly-developed innovative laser technology for the treatment of Peripheral Artery Disease ((PAD)), including Critical Limb Ischemia ((CLI)) and In-Stent Restenosis (ISR) with minimal impact on vessel walls. Jim Clemmer, AngioDynamics’ President and CEO said, “We have already seen a very positive response from initial users of the Auryon System, which has led to a rapid expansion of markets and geographies. AngioDynamics is proud to make the Auryon Atherectomy System, and its solid-state laser technology, available to providers and patients nationwide.” According to the American Heart Association, PAD affects 8.5M Americans and 200M people worldwide each year.

For further details see:

AngioDynamics launches Auryon Atherectomy System in U.S.